These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3938942)

  • 21. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)].
    Sherry S
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):517-24. PubMed ID: 6769032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiplatelet agents: their role in the prevention of sudden death.
    Hirsh J
    Ann N Y Acad Sci; 1982; 382():289-304. PubMed ID: 7044244
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
    Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in arrhythmia therapy.
    Rodman J; Benditt D
    Clin Pharm; 1983; 2(4):307-11. PubMed ID: 6883960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
    Chesebro JH; Fuster V
    J Thorac Cardiovasc Surg; 1982 Jan; 83(1):90-3. PubMed ID: 7033674
    [No Abstract]   [Full Text] [Related]  

  • 29. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Arrhythmia behavior and sudden heart death in isolated stenoses or obstructions of the anterior interventricular branch].
    Trappe HJ; Hartwig CA; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1985 Mar; 74(3):165-74. PubMed ID: 3993158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic consequences of newer studies addressing the problem of myocardial ischemia and ventricular arrhythmias.
    Kuck KH; Siebels J; Schneider MA
    Herz; 1995 Jun; 20(3):213-8. PubMed ID: 7635402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacology of ethacizin].
    Kaverina NV; Skoldinov AP; Senova ZP; Gritsenko AN; Lyskovtsev VV
    Farmakol Toksikol; 1985; 48(5):43-9. PubMed ID: 3908141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    J Am Coll Cardiol; 1996 Nov; 28(5):1119-26. PubMed ID: 8890804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic prospects and prostaglandins in vascular pathology].
    Courillon-Mallet A; Wautier JL
    Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():63-8. PubMed ID: 3938943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
    Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
    Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandins in the management of cardiac and skeletal muscle ischemia.
    Belkin M; Blebea J; Wright JG; Hobson RW
    Microcirc Endothelium Lymphatics; 1989; 5(3-5):335-49. PubMed ID: 2484090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.